Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2025-12-24 @ 9:06 PM
NCT ID: NCT00392704
Eligibility Criteria: Inclusion Criteria: * Clinically confirmed head \& neck cancer * Considered low cure rate with local therapy * No prior treatment for this cancer * Able to be up \& about and perform self care * Adequate renal and liver function * Must be 18 years of age or older * All patients will need an indwelling central venous access catheter * Must be able to give written informed consent Exclusion Criteria: * Active cancer treatment in the last 5 years * Pregnant or lactating women * History of stroke, transient ischemic attacks, or acute myocardial infarction within the past 6 months or any other serious cardiovascular disease * History of neurological disease * Recent history of blood in the sputum or vomitus * Non-healing wounds, ulcer or long bone fractures * History of bleeding problems or coagulation problems * History of abdominal fistula, gastrointestinal perforation or intrabdominal abscess within 6 months * History of uncontrolled hypertension * Symptomatic peripheral vascular disease Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have. You can then decide if you wish to participate.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT00392704
Study Brief:
Protocol Section: NCT00392704